MarketView for June 11

MarketView for Wednesday, June 11
 

 

 

MarketView

 

Events defining the day's trading activity on Wall Street

 

Lauren Rudd

 

Wednesday, June 11, 2014

 

 

Dow Jones Industrial Average

16,843.88

q

-102.04

-0.60%

Dow Jones Transportation Average

8,141.55

q

-62.74

-0.76%

Dow Jones Utilities Average

537.50

q

-6.66

-1.22%

NASDAQ Composite

4,331.93

q

-6.07

-0.14%

S&P 500

1,943.89

q

-6.90

-0.35%

 

Summary

 

The S&P 500's drop of 0.4 percent was its biggest daily percentage loss since May 20. The benchmark index fell for the second day in a row, after four straight record closing highs. The selloff was broad. Every S&P 500 sector index except energy .SPNY declined for the day. Low volume and low volatility have marked recent sessions, leaving indexes to trade in a narrow range.

 

The World Bank's lower growth forecast provided investors with a reason to unload some stocks. Late Tuesday, the World Bank cut its global economic growth forecast for 2014 to 2.8 percent from 3.2 percent because of a harsh U.S. winter and the impact of the Ukraine crisis.

 

The largest drag on the S&P 500 was Bank of America, down 2.1 percent at $15.59. The bank has reached an impasse in negotiating a multibillion-dollar settlement with the Department of Justice related to the bank's mortgage investments, according to The New York Times.

 

Investors turned cautious after the surprising primary election defeat of Eric Cantor, the No. 2 Republican in the House of Representatives, by an upstart candidate from the Tea Party movement.

 

Micron Technology rose 5 percent to $30.99 a day after Credit Suisse raised its price target on the memory chipmaker's stock to $50 from $30.

 

The CBOE Volatility Index .VIX rose 5.6 percent to 11.60 but remained well below its historical average of 20. In a sign of the market's low volatility, the 14-day Average True Range on the S&P 500 fell to 9.71, the lowest since February 2013.

 

Orexigen Therapeutics was down 14.7 percent to $5.81 after the Food and Drug Administration delayed a decision on the marketing application for its obesity drug by three months.

 

Volume was once again below average with approximately 5.2 billion shares changing hands on the major equity exchanges, a number that was below the 5.76 billion share average for the last month, according to data from BATS Global Markets.